Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - July 2013

The Many Faces of Drug Metabolism

07 Jul 2013 - 12 Jul 2013 - Holderness, NH, USA

Bookmark and Share

The attendees of the meeting include scientists from academia, industry and regulatory groups. The presentations will focus on cutting-edge science including unpublished data, exploring the many facets of the field, including sessions on important biochemical processes (e.g., Phase II enzymes and non-CYP oxidases), the role of drug metabolism in etiology of cancer, including bioactivation, and PK/PD relationships. The program will also have a session on new and emerging technologies. To kick-off the meeting, a keynote address will take place on Sunday evening. There will be morning and evening sessions on each day; the morning sessions having four speakers and the evening sessions having three. In keeping with past tradition, the Wednesday evening session will feature six graduate students and/or postdoctoral fellows who will be selected from the many outstanding posters submitted. The poster sessions will be organized by Vice Chair Ken Korzekwa and participants are encouraged to submit poster presentations. With the afternoons free, the attendees are encouraged to enjoy the many outdoor recreational activities in the NH area. Some afternoon activities that are part of the Drug Metabolism GRC tradition will again take place, including tennis or hiking on Monday, the "Industry versus Academia" softball game on Tuesday (no experience required, bring your gloves) and a golf outing on Wednesday. The casual nature of the meeting and collegial atmosphere is highly conducive to informal interactions with ample time to get to know your colleagues, network and perhaps establish collaborations. As always, the registration fee includes housing and meals.

Further information
Scientific News
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
A Simple Tool for Clinical and Postmortem Toxicological Analysis
In this study, GC-MS is used for the determination of clozapine, and five antidepressants in human plasma, serum and whole blood.
Influential Cancer Researcher Receives Agilent Thought Leader Award
Biologist Scott Lowe receives award in recognition for his contributions to cancer biology.
Gene-Editing Cures Genetic Blood Disorder in Mice
New technology may offer minimally invasive treatment for genetic disorders of the blood.
Antibodies from Ebola Survivors Neutralize Virus, Protect Lab Mice
Scientists discover antiboides generated from the blood of Ebola survivors can strongly combat the virus in the lab.
Immunotherapy Technique Holds Promise for Curing Food Allergies
Scientists develop immunotherapy technique that almost eliminating allergic response and anaphylactic response in food-allergic mice.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
Editing Gene Mutations in Anemia
Researchers successfully use a new gene editing strategy to correct mutations that cause a form of anemia.
Observing Direct Inheritance of Gene-Silencing RNA
Research has allowed for the observation of double-stranded RNA molecule being passed from parent to offspring in roundworms.
Fighting Cancer with Immune Response
New treatment elicits two-pronged immune response that destroys tumors in mice.
Scroll Up
Scroll Down

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos